Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ANDREW BADACHHAPE and ANANTH ANNAPRAGADA.
ANDREW BADACHHAPE
Connection Strength
3.767
ANANTH ANNAPRAGADA
  1. Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 02; 160:100-106.
    View in: PubMed
    Score: 0.897
  2. Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS). medRxiv. 2023 Mar 24.
    View in: PubMed
    Score: 0.793
  3. Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
    View in: PubMed
    Score: 0.594
  4. Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
    View in: PubMed
    Score: 0.192
  5. A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
    View in: PubMed
    Score: 0.189
  6. Nanoprobes for Computed Tomography and Magnetic Resonance Imaging in Atherosclerosis Research. Methods Mol Biol. 2022; 2419:809-823.
    View in: PubMed
    Score: 0.182
  7. Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
    View in: PubMed
    Score: 0.167
  8. Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
    View in: PubMed
    Score: 0.158
  9. A Hyperfluorinated Hydrophilic Molecule for Aqueous 19F MRI Contrast Media. Contrast Media Mol Imaging. 2018; 2018:1693513.
    View in: PubMed
    Score: 0.147
  10. Microglia-Specific Molecular Magnetic Resonance Imaging Probe Enables Noninvasive Separation of Parkinsonian Mice from Controls. bioRxiv. 2026 Jun 26.
    View in: PubMed
    Score: 0.062
  11. Reconstruction of glymphatic transport fields from subject-specific imaging data, with particular emphasis on cerebrospinal fluid flow and tracer conservation. ArXiv. 2026 May 01.
    View in: PubMed
    Score: 0.061
  12. Nano-radiomics of molecular MRI for early amyloid associated patterns in an Alzheimer's disease mouse model via an automatic pipeline. BMC Med Imaging. 2026 04 10; 26(1).
    View in: PubMed
    Score: 0.061
  13. Nanoparticle contrast-enhanced computed tomography and magnetic resonance imaging of vascularization of a subcutaneous niche for islet transplantation. Bioeng Transl Med. 2025 May; 10(3):e10740.
    View in: PubMed
    Score: 0.056
  14. A dual target molecular magnetic resonance imaging probe for noninvasive profiling of pathologic alpha-synuclein and microgliosis in a mouse model of Parkinson's disease. Front Neurosci. 2024; 18:1428736.
    View in: PubMed
    Score: 0.054
  15. Advances in nanoprobes for molecular MRI of Alzheimer's disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr; 16(2):e1946.
    View in: PubMed
    Score: 0.053
  16. Intratumoral nanofluidic system enhanced tumor biodistribution of PD-L1 antibody in triple-negative breast cancer. Bioeng Transl Med. 2023 Nov; 8(6):e10594.
    View in: PubMed
    Score: 0.051
  17. Rational Design of a Self-Assembling High Performance Organic Nanofluorophore for Intraoperative NIR-II Image-Guided Tumor Resection of Oral Cancer. Adv Sci (Weinh). 2023 04; 10(10):e2206435.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.